SPELA GASPERLIN: Open Payments
NPI 1902360746 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,399 in 46 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $161 · 2025 $3,399
Travel & lodging: $2,153Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 22 | $1,967 |
| Boston Scientific Corporation | 5 | $863 |
| Amneal Pharmaceuticals LLC | 2 | $184 |
| ACADIA Pharmaceuticals Inc | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $37 |
| Janssen Biotech, Inc. | 1 | $27 |
| MDD US Operations, LLC | 1 | $26 |
Products named: PERCEPT PC BRAINSENSE, Vercise, CREXONT, NUPLAZID, Qelbree, KEVEYIS, AUSTEDO XR, Gocovri.
Industry payments across KS — which companies pay providers there.
